ANTI-PLA2R ANTIBODY AND PRIMARY MEMBRANOUS NEPHROPATHY: A LITERATURE REVIEW (Atena Editora) (original) (raw)
Evaluation of anti-PLA2R1 as measured by a novel ELISA in patients with idiopathic membranous nephropathy: a cohort study
jan willem cohen tervaert
American journal of clinical pathology, 2014
View PDFchevron_right
Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
Vivekanand Jha
Kidney International Reports, 2017
View PDFchevron_right
Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy
Jan Willem Cohen Tervaert
American journal of nephrology, 2015
View PDFchevron_right
Anti-PLA2R-associated membranous nephropathy: a review with emphasis on diagnostic testing methods
Mark Haas
Clinical Nephrology, 2015
View PDFchevron_right
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy
Pierre Ronco, Vladimir Tesar, Hanna Debiec
Nephrology Dialysis Transplantation, 2013
View PDFchevron_right
Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years
Hanna Debiec
PloS one, 2017
View PDFchevron_right
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
Marisa Martin
2021
View PDFchevron_right
Circulating Anti-PLA2R Autoantibodies to Monitor Immunological Activity in Membranous Nephropathy
Paolo Cravedi
Journal of the American Society of Nephrology, 2011
View PDFchevron_right
Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era
Rivka Ayalon
Pediatric Nephrology, 2019
View PDFchevron_right
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
Shelley Harris
Kidney International, 2013
View PDFchevron_right
Rituximab in the treatment of PLA2R-associated membranous nephropathy: Insights from a hospital centre experience
mica pomper
2024
View PDFchevron_right
Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy
Henry HL Wu
Clinical Kidney Journal, 2022
View PDFchevron_right
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
F. Fervenza
Journal of the American Society of Nephrology, 2011
View PDFchevron_right
Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings
Saime Paydas
International Journal of Clinical Practice, 2020
View PDFchevron_right
Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
Mohd Fauzi
PLOS ONE, 2019
View PDFchevron_right
Immune Response against Autoantigen PLA2R Is not Gambling: Implications for Pathophysiology, Prognosis, and Therapy
Hanna Debiec
Journal of the American Society of Nephrology, 2015
View PDFchevron_right
Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy
Laura Croce
Journal of Immunology Research
View PDFchevron_right
Identification of a Major Epitope Recognized by PLA2R Autoantibodies in Primary Membranous Nephropathy
Ronan O'Cualain
Journal of the American Society of Nephrology, 2014
View PDFchevron_right
Primary Membranous Nephropathy
William Couser
Clinical Journal of the American Society of Nephrology
View PDFchevron_right
Circulating (CD3−CD19+CD20−IgD−CD27highCD38high) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
Ingrid Beukinga
Mediators of Inflammation, 2016
View PDFchevron_right
An Evaluation of the Level of Anti-phospholipase A2 Receptor (PLA2R) Antibody in Different Pathological Types of Glomerulonephritis
mubabol journal
Journal of Babol University of Medical Sciences, 2017
View PDFchevron_right
Circulating (CD3−CD19+CD20−IgD−CD27highCD38high) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?
Karen Willard-Gallo
Mediators of Inflammation, 2016
View PDFchevron_right
Anti -phospholipase A2 receptor antibodies in the diagnosis of idiopathic membranous nephropathy
Maria José Santos
2015
View PDFchevron_right
PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians
Vivekanand Jha
View PDFchevron_right
Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
Baoli Liu
Frontiers in Immunology, 2019
View PDFchevron_right
Antiphospholipase 2 receptor antibody levels to predict complete spontaneous remission in primary membranous nephropathy
Ana Matas
Clinical Kidney Journal, 2018
View PDFchevron_right
Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy
P. van Paassen, jan willem cohen tervaert
American Journal of Kidney Diseases, 2013
View PDFchevron_right
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy
Joel Polidori
Journal of the American Society of Nephrology : JASN, 2015
View PDFchevron_right
Treatment of primary membranous nephropathy: where are we now?
Antonello Pani
Journal of nephrology, 2017
View PDFchevron_right
#6905 Prevalence of ANTIPLA2R Antibodies in Egyptian Patients with Nephrotic Syndrome
Magdy El-Sharkawy
Nephrology Dialysis Transplantation, 2023
View PDFchevron_right
Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report
Rivka Ayalon
American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015
View PDFchevron_right
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
Antonella Tabucchi
Journal of Nephrology, 2020
View PDFchevron_right